Today: 13 June 2026
Bank of America stock jumps with big-bank rally as investors brace for payrolls and Jan. 14 earnings
5 January 2026
1 min read

Bank of America stock jumps with big-bank rally as investors brace for payrolls and Jan. 14 earnings

New York, Jan 5, 2026, 13:24 EST — Regular session

  • Bank of America shares rise about 2% as U.S. financial stocks lead Wall Street higher
  • Traders rotate into banks ahead of Friday’s U.S. payrolls report and the start of earnings season
  • Barclays lifts its price target on BAC; the bank’s quarterly results are due Jan. 14

Bank of America shares rose 2.2% to $57.17 in afternoon trading on Monday, moving with a broad rally in U.S. bank stocks that helped lift Wall Street’s main indexes.

The move matters because investors are repositioning early in the year, rotating into financials after a late-2025 tech pullback and ahead of a key run of economic and earnings catalysts. Financials were up about 2.5% on the day, Reuters reported.

Banks are sensitive to interest-rate expectations because higher rates can boost the spread between what lenders earn on loans and pay on deposits. Markets are pricing roughly 60 basis points — 0.60 percentage point — of Federal Reserve rate cuts in 2026, Reuters said, with attention turning to Friday’s monthly U.S. nonfarm payrolls report.

“The mood has been favoring financial stocks in recent days,” said Steve Sosnick, chief market analyst at Interactive Brokers, pointing to a broader risk-on tone. Reuters

Bank of America touched an intraday high of $57.54, within reach of the stock’s 52-week high of about $57.55, based on widely tracked market data.

On the analyst front, Barclays raised its price target on Bank of America to $71 from $59 and reiterated an “Overweight” rating — meaning it recommends holding more of the stock than a benchmark allocation — according to TheFly. TipRanks

The next major company catalyst is Bank of America’s quarterly report. The lender is scheduled to release results for the fourth quarter of 2025 on Wednesday, Jan. 14, at about 6:45 a.m. ET, followed by an investor call at 8:30 a.m. ET, the company said.

Investors will be watching net interest income — the difference between interest earned and interest paid — along with expense trends and signs of credit stress as the economy absorbs shifting rate expectations.

But the bank rally faces a near-term test: a stronger-than-expected payrolls report could force traders to scale back rate-cut bets, tightening financial conditions and weighing on rate-sensitive sectors.

Bank of America was moving broadly in step with peers on Monday, with JPMorgan up about 3.5%, Citigroup up about 4.3% and Wells Fargo up about 1.7%, while the Financial Select Sector SPDR Fund gained about 2.7%.

The next catalysts are Friday’s U.S. nonfarm payrolls report and Bank of America’s Jan. 14 earnings release and conference call.

Stock Market Today

  • Telix Pharmaceuticals Phase 3 ProstACT Safety Data Boosts Investment Outlook
    June 12, 2026, 8:05 PM EDT. Telix Pharmaceuticals (ASX:TLX) announced early Phase 3 ProstACT trial data for TLX591-Tx in metastatic castration-resistant prostate cancer, demonstrating an acceptable safety and tolerability profile with no new safety concerns. The lower kidney and salivary gland exposure compared to existing therapies could signal a differentiated advantage. This supports Telix's shift from diagnostics to higher-value therapeutics but hinges on upcoming pivotal trial results. A new U.S. collaboration with United Imaging aims to enhance theranostics workflow and commercial scale. Despite promising clinical progress, risks include regulatory scrutiny following an SEC subpoena over prostate cancer disclosures. Analysts forecast 22.7% annual revenue growth to A$1.2 billion by 2029, with an 85% upside to Telix's current price. Market watchers weigh potential regulatory and execution challenges against long-term growth prospects in theranostics.

Latest articles

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

13 June 2026
SGH closed at A$41.51, up 0.70% but underperformed the S&P/ASX 200’s 1.98% surge, as investors weighed solid cash flow and Boral margin gains against a high 36.03 P/E, mixed demand, and M&A risk; the next key catalyst is FY26 results on August 11, with analysts’ average target at A$47.64, 14.76% above Friday’s close.
NCR Voyix Rallies 10% After Investors Shift on Turnaround Bets

NCR Voyix Rallies 10% After Investors Shift on Turnaround Bets

13 June 2026
NCR Voyix soared 10.25% to $7.85, far outpacing the market, as investors focus on the company’s 2026 cash-flow and earnings targets; the next key catalyst is the Q2 2026 earnings update, with stock valuation appearing low if management delivers on margin and cash-flow goals, but risks remain with declining reported revenue and high debt.
NuScale Power stock jumps 16% as House sets ‘New Nuclear Era’ hearing — what’s next for SMR
Previous Story

NuScale Power stock jumps 16% as House sets ‘New Nuclear Era’ hearing — what’s next for SMR

3.5 million hit by University of Phoenix data breach as school rolls out “credit for prior learning” push
Next Story

3.5 million hit by University of Phoenix data breach as school rolls out “credit for prior learning” push

Go toTop